Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| PMCB (PharmaCyte Biotech, Inc.) | 1.39% | -33.03% | -38.71% | 135.87% | 26.42% | NA | NA | … | … |
Data as of 06/04/2026, Common starting date is 01/03/2013
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| PMCB (PharmaCyte Biotech, Inc.) | 01/03/2013 | 06/04/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -15.12 | -33.03 | -38.71 | 135.87 | 26.42 | NA | NA | … | … | 1.39 | -54.78 | -27.31 | -26.28 | 17.20 | 37,213.43 | -83.25 | 0.00 | -33.33 | -60.00 | 200.00 | -72.22 | 80.00 | 233.33 |
| Sharpe Ratio | NA | -0.23 | -0.56 | 0.44 | 0.10 | NA | NA | … | … | 0.46 | -0.66 | -0.58 | -0.89 | 0.37 | 52.35 | -0.33 | -0.01 | -0.35 | -0.54 | 1.36 | -0.70 | 0.72 | 1.66 |
| Standard Deviation(%) | NA | 94.51 | 70.42 | 319.25 | 255.69 | NA | NA | … | … | 85.72 | 88.14 | 58.42 | 34.66 | 42.93 | 710.90 | 254.49 | 167.58 | 99.89 | 112.81 | 145.69 | 103.64 | 111.05 | 142.17 |
| Draw Down(%) | NA | 46.72 | 80.19 | 96.27 | 97.38 | NA | NA | … | … | 34.34 | 65.19 | 41.67 | 36.79 | 31.05 | 86.51 | 93.00 | 50.00 | 60.00 | 80.00 | 62.50 | 77.27 | 66.67 | 52.38 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/04/2026, Common starting date is 01/03/2013
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PMCB (PharmaCyte Biotech, Inc.) |
-51.85%
Dec 2017 – Dec 2020 |
-41.92%
Nov 2015 – Nov 2020 |
17.19%
Feb 2014 – Feb 2024 |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PMCB (PharmaCyte Biotech, Inc.) |
624.21%
Nov 2020 – Nov 2023 |
199.31%
Jul 2016 – Jul 2021 |
50.60%
Feb 2013 – Feb 2023 |
0.00%
NA |
Annualized Rolling Returns Comparison Chart